Annual Operating Expenses
$60.12 M
+$17.32 M+40.48%
December 1, 2024
Summary
- As of March 13, 2025, ALDX annual total operating expenses is $60.12 million, with the most recent change of +$17.32 million (+40.48%) on December 1, 2024.
- During the last 3 years, ALDX annual operating expenses has risen by +$3.90 million (+6.93%).
- ALDX annual operating expenses is now -4.09% below its all-time high of $62.68 million, reached on December 31, 2022.
Performance
ALDX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$16.58 M
+$440.20 K+2.73%
December 1, 2024
Summary
- As of March 13, 2025, ALDX quarterly total operating expenses is $16.58 million, with the most recent change of +$440.20 thousand (+2.73%) on December 1, 2024.
- Over the past year, ALDX quarterly operating expenses has increased by +$10.48 million (+171.87%).
- ALDX quarterly operating expenses is now -13.04% below its all-time high of $19.06 million, reached on September 30, 2019.
Performance
ALDX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ALDX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.5% | +171.9% |
| 3 y3 years | +6.9% | +7.6% |
| 5 y5 years | +6.4% | +29.2% |
ALDX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.1% | +40.5% | -7.9% | +171.9% |
| 5 y | 5-year | -4.1% | +73.4% | -7.9% | +171.9% |
| alltime | all time | -4.1% | +5295.5% | -13.0% | >+9999.0% |
Aldeyra Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $60.12 M(+40.5%) | $16.58 M(+2.7%) |
| Sep 2024 | - | $16.14 M(-10.4%) |
| Jun 2024 | - | $18.01 M(+91.7%) |
| Mar 2024 | - | $9.39 M(+54.1%) |
| Dec 2023 | $42.79 M(-31.7%) | $6.10 M(-36.2%) |
| Sep 2023 | - | $9.55 M(-7.7%) |
| Jun 2023 | - | $10.34 M(-38.4%) |
| Mar 2023 | - | $16.80 M(+22.7%) |
| Dec 2022 | $62.68 M(+11.5%) | $13.70 M(-7.4%) |
| Sep 2022 | - | $14.78 M(-16.5%) |
| Jun 2022 | - | $17.71 M(+7.5%) |
| Mar 2022 | - | $16.48 M(+7.0%) |
| Dec 2021 | $56.22 M(+62.2%) | $15.40 M(-0.2%) |
| Sep 2021 | - | $15.44 M(+6.2%) |
| Jun 2021 | - | $14.54 M(+34.3%) |
| Mar 2021 | - | $10.83 M(+13.6%) |
| Dec 2020 | $34.67 M(-38.6%) | $9.53 M(+13.6%) |
| Sep 2020 | - | $8.39 M(+18.1%) |
| Jun 2020 | - | $7.11 M(-26.3%) |
| Mar 2020 | - | $9.64 M(-24.9%) |
| Dec 2019 | $56.51 M(+42.3%) | $12.83 M(-32.7%) |
| Sep 2019 | - | $19.06 M(+38.3%) |
| Jun 2019 | - | $13.78 M(+27.2%) |
| Mar 2019 | - | $10.83 M(-2.4%) |
| Dec 2018 | $39.70 M | $11.10 M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $10.95 M(+19.4%) |
| Jun 2018 | - | $9.17 M(+7.9%) |
| Mar 2018 | - | $8.49 M(+20.5%) |
| Dec 2017 | $22.49 M(+20.3%) | $7.05 M(+40.5%) |
| Sep 2017 | - | $5.02 M(-5.9%) |
| Jun 2017 | - | $5.33 M(+4.6%) |
| Mar 2017 | - | $5.10 M(+9.5%) |
| Dec 2016 | $18.70 M(+55.9%) | $4.65 M(-2.6%) |
| Sep 2016 | - | $4.78 M(+11.2%) |
| Jun 2016 | - | $4.30 M(-13.5%) |
| Mar 2016 | - | $4.97 M(+14.5%) |
| Dec 2015 | $11.99 M(+64.9%) | $4.34 M(+30.0%) |
| Sep 2015 | - | $3.34 M(+51.4%) |
| Jun 2015 | - | $2.20 M(+4.5%) |
| Mar 2015 | - | $2.11 M(-12.5%) |
| Dec 2014 | $7.27 M(+97.8%) | $2.41 M(+22.5%) |
| Sep 2014 | - | $1.97 M(+19.5%) |
| Jun 2014 | - | $1.65 M(+32.3%) |
| Mar 2014 | - | $1.24 M(+1.0%) |
| Dec 2013 | $3.68 M(+230.0%) | $1.23 M(+5.7%) |
| Sep 2013 | - | $1.17 M(+18.3%) |
| Jun 2013 | - | $985.70 K(+238.1%) |
| Mar 2013 | - | $291.50 K(+150.4%) |
| Dec 2012 | $1.11 M(-47.2%) | $116.40 K |
| Dec 2011 | $2.11 M | - |
FAQ
- What is Aldeyra Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual operating expenses year-on-year change?
- What is Aldeyra Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly operating expenses year-on-year change?
What is Aldeyra Therapeutics annual total operating expenses?
The current annual operating expenses of ALDX is $60.12 M
What is the all time high annual operating expenses for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual total operating expenses is $62.68 M
What is Aldeyra Therapeutics annual operating expenses year-on-year change?
Over the past year, ALDX annual total operating expenses has changed by +$17.32 M (+40.48%)
What is Aldeyra Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ALDX is $16.58 M
What is the all time high quarterly operating expenses for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly total operating expenses is $19.06 M
What is Aldeyra Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ALDX quarterly total operating expenses has changed by +$10.48 M (+171.87%)